NSCLC clinical trials at UCSF
1 in progress, 0 open to new patients
A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer
Sorry, in progress, not accepting new patients
The purpose of this study is to determine if MEDI4736 will be adequately tolerated in combination with tremelimumab in subjects with advanced non-small cell lung cancer (NSCLC).
San Francisco, California and other locations